Back to search
FDAFDA · Food and drugs·Recall number D-0636-2021

Diflorasone Diacetate Ointment USP, 0.05%, packaged in a)15 g (NDC 52565-063-15) and b) 30 g (NDC 52565-063-30) tubes, Rx only, Manufactured by: Teligent Pharma, Inc, Buena, NJ 08310.

Published June 30, 2021 · Recall initiated: May 14, 2021

Summary

FDA records drug Class II recall D-0636-2021, published June 30, 2021 and initiated May 14, 2021. Recalling firm: Teligent Pharma, Inc.; Status: Terminated; Reported quantity: 6,240 tubes; Lot: Lot #: 16264, Exp Date Nov 2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foreign Substance: Foreign particles observed during routine stability testing.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Teligent Pharma, Inc.
Distributor
Nationwide in the United States
Lot
Lot #: 16264, Exp Date Nov 2022
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Diflorasone Diacetate Ointment USP, 0.05%, packaged in a)15 g (NDC 52565-063-15) and b) 30 g (NDC 52565-063-30) tubes, Rx only, Manufactured by: Teligent Pharma, Inc, Buena, NJ 08310. recalled?

Yes. FDA published recall D-0636-2021 on June 30, 2021. Reported hazard: Presence of Foreign Substance: Foreign particles observed during routine stability testing.

What should I do if I have this product?

Voluntary: Firm initiated · Letter